ERBB2 and cancer: Aberrant HER2 activity and the activation of the HER2 receptor in human gastric tumors leads to receptor heterodimerization, mainly with HER3 and HER4 receptors [40], triggering a complex signal transduction cascade that modulates cancer cell survival, proliferation, mobility and invasiveness [41].